tiprankstipranks
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
NASDAQ:SHPH
US Market

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Stock Price & Analysis

17 Followers

SHPH Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.35 - $2.75
Previous Close$0.42
Volume13.46K
Average Volume (3M)115.52K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$6.81M
Total Debt (Recent Filing)$503.84K
Price to Earnings (P/E)-1.0
Beta3.86
Nov 14, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.44
Shares Outstanding16,794,893
10 Day Avg. Volume45,206
30 Day Avg. Volume115,517
Standard Deviation0.27
R-Squared0.04
Alpha-0.16
Financial Highlights & Ratios
Price to Book (P/B)1.68
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.60
P/FCF Ratio2.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

33.93%0.22%0.30%65.55%
33.93% Insiders
0.30% Other Institutional Investors
65.55% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

SHPH FAQ

What was Shuttle Pharmaceuticals Holdings, Inc.’s price range in the past 12 months?
Shuttle Pharmaceuticals Holdings, Inc. lowest stock price was $0.35 and its highest was $2.75 in the past 12 months.
    What is Shuttle Pharmaceuticals Holdings, Inc.’s market cap?
    Currently, no data Available
    When is Shuttle Pharmaceuticals Holdings, Inc.’s upcoming earnings report date?
    Shuttle Pharmaceuticals Holdings, Inc.’s upcoming earnings report date is Nov 14, 2023 which is 164 days ago.
      How were Shuttle Pharmaceuticals Holdings, Inc.’s earnings last quarter?
      Shuttle Pharmaceuticals Holdings, Inc. released its earnings results on Aug 15, 2023. The company reported -$0.153 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.153.
        Is Shuttle Pharmaceuticals Holdings, Inc. overvalued?
        According to Wall Street analysts Shuttle Pharmaceuticals Holdings, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Shuttle Pharmaceuticals Holdings, Inc. pay dividends?
          Shuttle Pharmaceuticals Holdings, Inc. does not currently pay dividends.
          What is Shuttle Pharmaceuticals Holdings, Inc.’s EPS estimate?
          Shuttle Pharmaceuticals Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Shuttle Pharmaceuticals Holdings, Inc. have?
          Shuttle Pharmaceuticals Holdings, Inc. has 16,794,893 shares outstanding.
            What happened to Shuttle Pharmaceuticals Holdings, Inc.’s price movement after its last earnings report?
            Shuttle Pharmaceuticals Holdings, Inc. reported an EPS of -$0.153 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Shuttle Pharmaceuticals Holdings, Inc.?
              Currently, no hedge funds are holding shares in SHPH
              ---

              Shuttle Pharmaceuticals Holdings, Inc. Stock Smart Score

              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -68.76%
              12-Months-Change

              Fundamentals

              Return on Equity
              -112.37%
              Trailing 12-Months
              Asset Growth
              -31.22%
              Trailing 12-Months

              Company Description

              Shuttle Pharmaceuticals Holdings, Inc.

              Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              BioMarin Pharmaceutical
              Incyte
              Illumina
              Vertex Pharmaceuticals
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis